NCT07012499

Brief Summary

Although peritoneal dialysis (PD) is a representative renal replacement therapy along with hemodialysis, number of PD patients decreases every year. Among the various contributing factors for such trends, the essential issue that the patients should perform dialytic therapy by themselves is thought to be critical for the patients to avoid choosing PD as primary dialytic therapy. In particular, unlike hemodialysis, the patients with PD have troubles in getting timely medical advice in their daily life, although continuous advice are essential for maintaining therapy. Thus, remote monitoring and control system is believed to be useful in PD therapy. Automated PD (APD) is a good option because of its convenience and improved accessibility. So, in Korea, although the rate of incident PD patients was decreased, the proportion of APD were rapidly increased (3.7% in 2001 vs. 39% in 2018, Korean Society of Nephrology (KSN) data) In the COVID-19 pandemic, the investigators should improve Remote therapy monitoring (RTM). Technologies that collect medical information and transmit it to health care providers for patient management, have the potential to improve the patients' outcomes without visiting hospital receiving automated peritoneal dialysis (APD) at home. However, there are only a few retrospective studies and no prospective study about remote patients monitoring programs in APD. Remote medical service is currently illegal in South Korea. However, recently the Korean government has approved remote medical service in only a few areas of Gangwon province, including Wonju city, which belongs to our institution. Thus, the investigators aim to use such a benefit to investigate the 'Quality of Life (QOL)' in Korean patients undergoing APD. The investigators plan to compare the various clinical indexes, including mainly QOL, mental health focusing depression, and volume-nutritional status between the patients with previous classic APD and APD combined by the SharesourceTM system (Baxter Co.).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable quality-of-life

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable quality-of-life

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

June 10, 2025

Status Verified

June 1, 2025

Enrollment Period

29 days

First QC Date

February 24, 2025

Last Update Submit

June 9, 2025

Conditions

Keywords

remote controlAutomated peritoneal dialysis

Outcome Measures

Primary Outcomes (4)

  • changes of quality of life KDQOL-36

    6, 12 months

  • changes of quality of life PHQ-9

    6, 12 months

  • changes of quality of life BDI

    6, 12 months

  • changes of quality of life CESD

    6, 12 months

Secondary Outcomes (6)

  • change volume status

    6, 12 months

  • change nutrition status

    6, 12 months

  • dialysis adequacy

    6,12 months

  • Questionnaire form.

    6,12 months

  • adverse events

    12 months

  • +1 more secondary outcomes

Other Outcomes (2)

  • Total time or PD

    90 Days

  • Medical coast of treatment

    12 month

Study Arms (2)

APD with Sharesource

EXPERIMENTAL

Patients received APD with Sharesource system

Device: Automated peritoneal dialysis with Sharesource device

APD without Sharesource

PLACEBO COMPARATOR

Patients received APD without sharesource

Device: APD without sharesource

Interventions

Patients receive APD with an FMC device that contains sharesource software which can communicate with the medical team.

APD with Sharesource

Patients received APD with Same machine but this patients dose not using sharesource software

APD without Sharesource

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • More than 18 years old
  • ESRD patients on APD(≥1 month)
  • Consent to participate in the study

You may not qualify if:

  • Patients who plan to receive kidney transplantation within 1 year
  • Patients with co-morbidities: cardiovascular disease(myocardial infarction, heart failure, arrhythmia), cancer, psychiatric diseases, liver cirrhosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wonju Severance Christian Hospital

Wŏnju, Kangwondo, 26426, South Korea

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Comparison of the APD model with internet-based feedback system versus without it
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 24, 2025

First Posted

June 10, 2025

Study Start

December 1, 2025

Primary Completion

December 30, 2025

Study Completion

December 31, 2025

Last Updated

June 10, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations